Menu Menu


SNGX Financials       Clear


SNGX        0000812796    
Filing Date Form Type Description Document
2010-01-12 SC 13G/A View Document
2009-11-30 SC 13G View Document
2009-11-23 424B3 PRO SUPP FOR 10Q 3Q 2009 -162375 View Document
2009-11-23 424B3 PRO SUPP FOR 10Q 3Q 2009 -157322 View Document
2009-11-23 424B3 PRO SUPP FOR 10Q 3Q 2009 -149239 View Document
2009-11-13 8-K SOLIGENIX 8K FINANCIAL RESULTS 3Q 09 View Document
2009-11-13 10-Q SOLIGENIX 10-Q 3Q 2009 View Document
2009-11-12 4 FORM 4 View Document
2009-11-12 SC 13G/A SCHEDULE 13GA View Document
2009-10-20 EFFECT View Document
2009-10-20 424B3 PROSPECTUS View Document
2009-10-19 8-K SOLIGENIX 8K FIRST PATIENT View Document
2009-10-19 S-1/A AMENDED REGISTRATION STATEMENT View Document
2009-10-13 4 FORM 4 View Document
2009-10-13 3 FORM 3 View Document
2009-10-13 4 View Document
2009-10-09 8-K 8K_BOARDCHANGE View Document
2009-10-08 4 View Document
2009-10-07 S-1 REGISTRATION STATEMENT View Document
2009-10-02 SC 13D/A SIGMA TAU PHARMACEUTICALS/SOLIGENIX 13D AMENDMENT NO. 1 View Document
2009-10-02 SC 13D/A SIGMA TAU INTERNATIONAL/SOLIGENIX 13D AMENDMENT NO. 1 View Document
2009-10-02 SC 13D/A SIGMA TAU FINANZIARIA/SOLIGENIX 13D AMENDMENT NO. 1 View Document
2009-10-02 SC 13D/A SIGMA TAU AMERICA/SOLIGENIX 13D AMENDMENT NO. 1 View Document
2009-10-02 SC 13D/A PAOLO CAVAZZA/SOLIGENIX 13D AMENDMENT NO. 1 View Document
2009-10-02 SC 13D/A CLAUDIO/SOLIGENIX 13D AMENDMENT NO. 1 View Document
2009-10-01 8-K 8K_NAMECHANGE View Document
2009-09-30 4 FORM 4 View Document
2009-09-29 8-K CURRENT REPORT View Document
2009-09-28 4 FORM 4 View Document
2009-09-28 4 FORM 4 View Document
2009-09-28 4 FORM 4 View Document
2009-09-22 8-K DOR 8K NIH GRANT View Document
2009-08-21 424B3 PROSPECTUS SUPPLEMENT FOR 10Q 2Q 2009-149239 View Document
2009-08-21 424B3 PROSPECTUS SUPPLEMENT FOR 10Q 2Q 2009-157322 View Document
2009-08-14 10-Q DOR 10-Q 2Q 2009 View Document
2009-08-14 8-K DOR 8K FINANCIAL RESULTS 2Q 09 View Document
2009-08-11 4 View Document
2009-07-09 4 FORM 4 View Document
2009-07-09 3 FORM 3 View Document
2009-07-09 4 FORM 4 View Document
2009-07-09 4 FORM 4 View Document
2009-07-09 4 FORM 4 View Document
2009-07-07 8-K 8K FOR CHRISTOPHER SCHNITTKER View Document
2009-07-02 SC 13G BIOTEX SCHEDULE 13G View Document
2009-07-02 3 View Document
2009-07-02 SC 13G BIOTEX SCHEDULE 13G View Document
2009-05-18 424B3 PROSPECTUS SUPPLEMENT 157322 1Q09 View Document
2009-05-18 424B3 PROSPECTUS SUPPLEMENT FOR 10 Q 1Q 2009-149239 View Document
2009-05-15 8-K DOR 8K FINANCIAL RESULTS 1Q 09 View Document
2009-05-15 10-Q DOR 10Q FOR 1Q 2009 View Document
2009-05-14 424B3 PROSPECTUS FUSION EQUITY View Document
2009-05-06 EFFECT View Document
2009-04-27 POS AM POS AM FUSION LINE View Document
2009-04-24 DEFA14A NOTICE OF INTERNET 14A View Document
2009-04-17 EFFECT View Document
2009-04-17 424B3 PROSPECTUS FOR FEB. FINANCING 2009 View Document
2009-04-17 DEFR14A DEF 14A PROXY - REVISION View Document
2009-04-16 DEF 14A DEF 14A PROXY View Document
2009-04-15 CORRESP View Document
2009-04-15 CORRESP View Document
2009-04-14 S-1/A S1A FORM FOR DOR BIOPHARMA View Document
2009-04-02 PRE 14A PRE 14A PROXY View Document
2009-03-31 8-K DOR 8K ON FINANCIAL RESULTS 2008 View Document
2009-03-30 10-K DOR 10 K FOR 2008 View Document
2009-03-30 4 FORM 4 View Document
2009-03-30 3 FORM 3 View Document
2009-03-24 D View Document
2009-03-16 4 FORM 4 View Document
2009-03-16 3 FORM 3 View Document
2009-03-16 4 FORM 4 View Document
2009-03-16 3 FORM 3 View Document
2009-03-16 8-K 8K FOR NEW DIRECTOR LAPOINTE AND OFFICER HAMILTON View Document
2009-03-04 CT ORDER View Document
2009-02-27 D View Document
2009-02-25 UPLOAD View Document
2009-02-20 SC 13D DOR BIOPHARMA/SIGMA TAU PHARMACEUTICALS SCHEDULE 13D - 02/11/09 View Document
2009-02-20 SC 13D DOR BIOPHARMA/SIGMA TAU INTERNATIONAL SCHEDULE 13D - 02/11/09 View Document
2009-02-20 SC 13D DOR BIOPHARMA/SIGMA TAU FINANZIARIA SCHEDULE 13D - 02/11/09 View Document
2009-02-20 SC 13D DOR BIOPHARAM/SIGMA TAU AMERICA SCHEDULE 13D - 02/11/09 View Document
2009-02-20 SC 13D DOR BIOPHARMA/PAOLO CAVAZZA SCHEDULE 13D - 02/11/09 View Document
2009-02-20 SC 13D DOR BIOPHARAM/CLAUDIO CAVAZZA SCHEDULE 13D - 02/11/09 View Document
2009-02-13 S-1 S1 FORM FOR DOR BIOPHARMA View Document
2009-02-13 4 FORM 4 View Document
2009-02-13 4 FORM 4 View Document
2009-02-13 4 FORM 4 View Document
2009-02-03 D View Document
2009-01-21 8-K 8K FOR PIPE OF JAN 2009 DOR View Document
2009-01-16 8-K CHANGE IN AUDITORS View Document
2008-12-19 4 FORM 4 View Document
2008-12-19 4 FORM 4 View Document
2008-12-19 4 FORM 4 View Document
2008-12-05 D View Document
2008-12-03 SC 13G SIGMA-TAU PHARMACEUTICALS/DOR BIOPHARMA - SCHEDULE 13G View Document
2008-12-03 SC 13G SIGMA-TAU AMERICA/DOR BIOPHARMA - SCHEDULE 13G View Document
2008-12-03 SC 13G SIGMA-TAU INTERNATIONAL/DOR BIOPHARMA - SCHEDULE 13G View Document
2008-12-03 SC 13G SIGMA-TAU FINANZIAIARIA/DOR BIOPHARMA - SCHEDULE 13G View Document
2008-12-03 SC 13G CLAUDIO CAVAZZA/DOR DIOPHARMA - SCHEDULE 13G View Document
2008-12-03 SC 13G PAOLO CAVAZZA/DOR BIOPHARM SCHEDULE 13G View Document
2008-12-03 3 FORM 3 View Document
2008-12-03 3 FORM 3 View Document

Find registration statements, periodic reports, and other forms by typing ticker symbol of a company.

Ticker:

(402) 804-8299